BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Drug Discovery

Debiopharm and Aspen Partner to launch prostate cancer drug trelstar® in South Africa

In 2020, nearly 14,000 South African men were newly diagnosed with prostate cancer1 with an average of 5 men dying from the disease every day.2 I...

February 01, 2022 | News

I-Mab to Accelerate Commercialization of Innovative Biologics Drugs

This strategic partnership will accelerate I-Mab's commercialization strategy with an execution plan and timeline to commercialize its innovative assets, i...

January 31, 2022 | News

XtalPi Partners with Excelra for GOSTAR

Excelra, a leading global Data & Analytics organization, today announced the partnership for its Global Online Structure Activity Relationship Database...

January 19, 2022 | News

The Philippines Has Approved ReCOV For Phase II/III Clinical Trial

Recombinant Two-Component COVID-19 Vaccine (ReCOV) was approved for International Phase II/III Clinical Trial ReCOV induced high levels of neutralizing ...

January 18, 2022 | News

SANOFI to Advance ABL301 for the Treatment of Parkinson's Disease

ABL and SANOFI to collaborate on the development of ABL301, a potential first-in-class bispecific antibody targeting alpha-synuclein and containing a pro...

January 12, 2022 | News

CanSinoBIO Announces Approval for its MCV4 Product Menhycia™ in China

Leveraging CanSinoBIO's industry-leading synthetic biotechnology and formulation technology platform, Menhycia™ covalently binds common pathogen...

January 10, 2022 | News

Aurobindo rolls out molnaflu, oral covid drug for adult patients In India

Molnupiravir was earlier approved under Emergency Use Authorisation from CDSCO, India. This is the first oral antiviral approved by India, the UK agency an...

January 06, 2022 | News

SRI International Announces Collaboration Agreement with Janssen

SRI International (SRI) today announced the company has entered into a collaboration agreement with Janssen Pharmaceutica NV (Janssen), one of the Janssen ...

January 06, 2022 | News

Endo Launches First Generic Version of CUVPOSA® (glycopyrrolate) Oral Solution

"We're proud to provide families with a generic option of this important medication," said Jon Holden, Senior Vice President and General Manager, Gene...

January 05, 2022 | News

Taiwan FDA Has Accepted New Drug Application for Sacituzumab Govitecan

Everest Medicines Limited (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on developing and commercializing tra...

January 04, 2022 | News

SOPHiA GENETICS Hosts Symposium with GE Healthcare at RSNA 2021

Symposium encapsulates SOPHiA GENETICS and GE Healthcare alliance to provide joint solutions and multimodal analytics to healthcare providers and biopharma...

November 30, 2021 | News

Hetero and Shenzhen Beimei Pharmaceuticals launch antiviral drug Oselavir® in China

Hetero, a globally renowned vertically integrated pharmaceutical organization and Shenzhen Beimei Pharmaceuticals jointly announced that they have received...

November 12, 2021 | News

Merck and Ridgeback Announce Japanese Government to Purchase 1.6 Million Courses of Molnupiravir

Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced that the Japanese government will purch...

November 11, 2021 | News

Oncodesign and TiumBio Sign Collaboration Agreement for R&D of Fibrosis Drug Candidates

Oncodesign (ALONC – FR0011766229), a French biopharmaceutical company specialized in kinase inhibitor research and precision medicine, and TiumBio (K...

October 22, 2021 | News

Stay Connected